Biogen, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US09062X1037
USD
171.59
37.44 (27.91%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
2,454.80
2,561.50
2,336.00
2,337.60
2,375.70
2,353.00
2,200.30
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,454.80
2,561.50
2,336.00
2,337.60
2,375.70
2,353.00
2,200.30
Raw Material Cost
876.60
799.30
812.50
807.50
821.50
704.80
689.80
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
67.40
72.60
60.00
60.00
59.80
61.30
69.20
Selling and Distribution Expenses
594.80
583.80
572.50
680.00
588.40
553.80
581.50
Other Expenses
30.22
25.95
30.27
39.95
41.02
38.07
31.44
Total Expenditure (Excl Depreciation)
1,841.00
1,715.20
1,747.70
1,947.00
1,879.90
1,700.60
1,654.90
Operating Profit (PBDIT) excl Other Income
613.8000000000001
846.3
588.3
390.6
495.79999999999995
652.4
545.4
Other Income
18.50
6.00
35.80
-72.20
39.50
119.00
18.10
Operating Profit (PBDIT)
834.50
1,046.60
807.30
542.40
718.10
930.20
711.10
Interest
67.40
72.60
60.00
60.00
59.80
61.30
69.20
Exceptional Items
-7.60
-35.70
-252.90
2.30
-24.50
-11.40
-29.50
Gross Profit (PBDT)
1,578.20
1,762.20
1,523.50
1,530.10
1,554.20
1,648.20
1,510.50
Depreciation
202.20
194.30
183.20
224.00
182.80
158.80
147.60
Profit Before Tax
557.30
744.00
311.20
291.50
451.00
698.70
464.80
Tax
90.80
109.20
70.70
24.70
62.50
115.10
71.40
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
466.50
634.80
240.50
266.80
388.50
583.60
393.40
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
466.50
634.80
240.50
266.80
388.50
583.60
393.40
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
466.50
634.80
240.50
266.80
388.50
583.60
393.40
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
18,207.50
17,634.00
16,978.70
16,716.00
16,358.90
15,889.10
15,213.00
Earnings per share (EPS)
3.17
4.33
1.64
1.83
2.66
4.0
2.7
Diluted Earnings per share
3.17
4.33
1.64
1.83
2.66
4.0
2.7
Operating Profit Margin (Excl OI)
25.0%
33.04%
25.18%
16.71%
20.87%
27.73%
24.79%
Gross Profit Margin
30.94%
36.63%
21.16%
22.05%
26.68%
36.44%
27.83%
PAT Margin
19.0%
24.78%
10.3%
11.41%
16.35%
24.8%
17.88%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is -4.17% vs 9.65% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is -26.51% vs 163.95% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is -21.58% vs 34.88% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is -7.16% vs 21.00% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

Compare Quarterly Results Of Biogen, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
2,454.80
142.00
2,312.80
1,628.73%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,454.80
142.00
2,312.80
1,628.73%
Raw Material Cost
876.60
176.00
700.60
398.07%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
67.40
1.00
66.40
6,640.00%
Selling and Distribution Expenses
594.80
230.00
364.80
158.61%
Other Expenses
30.22
64.20
-33.98
-52.93%
Total Expenditure (Excl Depreciation)
1,841.00
1,049.00
792.00
75.50%
Operating Profit (PBDIT) excl Other Income
613.80
-907.00
1,520.80
167.67%
Other Income
18.50
90.00
-71.50
-79.44%
Operating Profit (PBDIT)
834.50
-760.00
1,594.50
209.80%
Interest
67.40
1.00
66.40
6,640.00%
Exceptional Items
-7.60
0.00
-7.60
Gross Profit (PBDT)
1,578.20
-34.00
1,612.20
4,741.76%
Depreciation
202.20
57.00
145.20
254.74%
Profit Before Tax
557.30
-818.00
1,375.30
168.13%
Tax
90.80
7.00
83.80
1,197.14%
Provisions and contingencies
0
0
0.00
Profit After Tax
466.50
-825.00
1,291.50
156.55%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
466.50
-825.00
1,291.50
156.55%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
466.50
-825.00
1,291.50
156.55%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
18,207.50
9,399.00
8,808.50
93.72%
Earnings per share (EPS)
3.17
-2.13
5.30
248.83%
Diluted Earnings per share
3.17
-2.13
5.30
248.83%
Operating Profit Margin (Excl OI)
25.00%
-638.73%
0.00
663.73%
Gross Profit Margin
30.94%
-535.92%
0.00
566.86%
PAT Margin
19.00%
-580.99%
0.00
599.99%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 245.48 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -4.17% vs 9.65% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 3.33% vs -2.44% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 46.65 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -26.51% vs 163.95% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 20.08% vs 668.81% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 81.60 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -21.58% vs 34.88% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 20.25% vs 115.29% in Sep 2024

Quarterly - Interest
Interest 6.74 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -7.16% vs 21.00% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 12.71% vs -6.27% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 25.00%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024